http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000009513-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71960e2a318c0057d632873dbd209192 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
filingDate | 1998-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd4f26fbf69557930c52ca10e6bf2c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49424a729a92476cf226bab67832eebb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328807fcf5be1e6718a55ddea263b94a |
publicationDate | 2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20000009513-A |
titleOfInvention | New RAS-like protein that specifically interacts with IκB, an inhibitor of NFκB |
abstract | The present invention relates to a novel Ras-like protein that specifically interacts with IκB, an inhibitor of NFκB, its genes, and a method for isolating it from mice. Specifically, the present invention relates specifically to IκB using a yeast 2 hybrid method from mice. Isolates new Ras-like proteins that interact with them to determine their gene sequence and amino acid sequence, and to characterize their inhibition of NFκB activation mediated by TNFα or IL-1. In this regard, it can be usefully used as an anti-inflammatory agent, an immunomodulator, an anticancer agent, and the like. |
priorityDate | 1998-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 255.